LAB-ON-A-CHIP AND MICROARRAYS (BIOCHIP) MARKET ANALYSIS

Lab-on-a-chip and Microarrays (Biochip) Market, By Type (Lab-on-a-chip and Microarray), By Product (Instruments, Reagents and Consumables, and Software and Services), By Application (Clinical Diagnostics, Drug Discovery, Genomics and Proteomics, and Other Application), By End User (Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostics Centers, and Academic and Research Institutes), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)-

Published In : Mar 2023
Code : CMI515
Pages :151
Formats :
Excel and PDF
Industry : Medical Devices

Leading Companies

Merck KgaA, QIAGEN NV, BioMérieux, Illumina Inc., Micronit BV, PerkinElmer Inc., Thermo Fisher Scientific, Fluidigm Corporation, Bio-Rad Laboratories Inc., Agilent Technologies Inc., Abbott Laboratories, Phalanx Biotech Group, and Danaher Corporation (Cepheid), among others.

Global Lab-on-a-chip and Microarrays (Biochip) Market: Key Companies Insights

The global lab-on-a-chip and microarrays (biochip) market is highly competitive. This is attributed to the increasing incidences of chronic diseases worldwide, as a result, players in the market are focusing on launching novel products in the market.

Some of the key players in the global lab-on-a-chip and microarrays (biochip) market are Merck KgaA, QIAGEN NV, BioMérieux, Illumina Inc., Micronit BV, PerkinElmer Inc., Thermo Fisher Scientific, Fluidigm Corporation, Bio-Rad Laboratories Inc., Agilent Technologies Inc., Abbott Laboratories, Phalanx Biotech Group, and Danaher Corporation (Cepheid), among others.